By ANDREW PARTON // It’s a challenging question: Can we be truly inspired by an event that occurred 50 years ago? The answer lies in the event’s impact – not just on us as individuals, but on a variety of aspects of society. In July 2019, we’ll celebrate the 50th anniversary of Apollo 11 and the landing of the first men on the surface of the moon. That event impacted not just the United States,…
Read More
By GREGORY ZELLER // A new gene therapy can literally rewire the brains of Parkinson’s disease patients – and may rewrite the book on treatment of the nation’s second most-common neurodegenerative disease. A team of scientists from the Manhasset-based Feinstein Institute for Medical Research has published findings indicating that AAV2-GAD, an emerging Parkinson’s gene therapy, creates new circuits in the brain promoting improved motor skills – setting up AAV2-GAD for a critical final found of…
Read More
By GREGORY ZELLER // A company veteran with a history of breaking glass ceilings has taken control of a Jericho company leading the patient-recruitment pack. Clinical Trial Media, self-billed as “the industry leader” in global clinical-trial patient recruitment and retention, has named Cara Brant as its new CEO. More accurately, Brant has named herself: The new chief executive, who started at the Jericho firm as a project coordinator in 2001, also on Wednesday announced her…
Read More
